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LIVING KIDNEY DONOR INFORMED CONSENT PRACTICES VARY 
BETWEEN U.S. AND NON-U.S. CENTERS 
Ami M. Parekh, Elisa J. Gordon, Amit X. Garg, Amy D. Waterman, Sanjay Kulkarni,   
and Chirag R. Parikh. (Yale University School of Medicine, New Haven, CT). 
ABSTRACT 
Living kidney donation rates are increasing in the United States and 
internationally. Major consensus statements on the care of living kidney donors 
recommend communicating all potential health and psychosocial risks to donors. We 
evaluated the degree of international variation in the process of informed consent of 
potential donors during their evaluation.  
Transplant professionals attending the 2006 World Transplant Congress 
responded to a survey assessing their informed consent processes, donor evaluation and 
risk communication to living donors. US based respondents were compared to non-US 
respondents. There were 221 respondents from 177 transplant centers and 40 countries 
(48% US respondents). Across US and non-US transplant centers, potential donors were 
most likely to receive written material about living donor risk by mail prior to evaluation, 
receive risk information in person during evaluation, have a psychosocial evaluation, 
which usually lasted longer than 30 minutes, and sign an official donation consent form 
presented to them by a surgeon or a nephrologist. Although over 75% of respondents 
stated that donors received information about medical risks such as hypertension, chronic 
kidney disease, and potential need for dialysis, there was less consistency regarding 
whether or not respondents conveyed an increased risk of these medical complications to 
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donors. Additionally, the financial and psychosocial costs associated with being a living 
donor were inconsistently communicated to donors during the informed consent process. 
Compared to non-US respondents, US respondents were more likely to use written 
material and visual aids to convey risks to donors, have mandatory psychosocial 
evaluations, and provide access to donor support groups. US transplant centers were also 
more likely to discuss the possibility of the donor needing dialysis or a transplant if their 
remaining kidney fails in the future, possible travel expenses and loss of work income 
due to donation recovery. Conversely, the US respondents’ centers were less likely to 
offer long-term follow up and to utilize nephrologists to obtain written donor consent for 
donation. 
As dependence on living organ donation increases best practices for informed 
consent, donor evaluation and uniform risk conveyance need to be established. This may 
be accomplished by using a model informed consent template to ensure that informed 
consent from donors is consistently obtained. 
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INTRODUCTION 
Due to the shortage of deceased donor kidneys and the increasing use of living 
donor kidneys from non-related and expanded criteria kidney donors1-3 , almost half of all 
kidneys donated in the United States come from living donors and the rates of living 
kidney donation internationally continue to increase.3, 4  The fundamental premise of 
living kidney transplantation is that the benefits to the recipient and potential 
psychosocial benefits to the donor significantly outweigh the possible health risks to the 
donor. The long term benefits for the recipient of transplantation of a kidney from a 
living donor are significantly better than the benefits of cadaveric transplantation.5  
Despite the improved outcomes for recipients living donor kidney transplantation 
challenges the core medical ethics principle, “first do no harm.”  
However, to date, the lack of a national registry, which would track all kidney 
donation outcomes, limits comprehensive understanding of the donor’s medical, financial 
and psychosocial risks.6-15  Although the risks of living kidney donation appear to be 
minimal, as with any major surgery there are some risks of donation.16  Additionally, if 
anything were to happen to the remaining kidney, there would be no backup. Also, even 
if kidney donation does not raise the risk of long-term medical problems such as 
hypertension, kidney donors who develop hypertension for other reasons may be more 
vulnerable to kidney damage from the high blood pressure. Additionally, it may be that 
the absence of discovered problems with living kidney donation is a reflection of the 
above average health of kidney donors17  which may change if centers begin using 
expanded criteria donors.  
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The ethical practice of medicine requires appropriate informed consent for 
medical procedures. Requiring physicians to disclose information to their patients 
regarding treatment preserves patient autonomy and self-determination by lessening the 
information asymmetry that exists between patient and physician. Informed consent for 
all medical procedures and treatment is especially necessary in today’s patient centered 
practice of medicine where the patient is expected not only to comply with a physician’s 
orders but to fully participate in his or her treatment decisions.  
In the case of living kidney donation, informed consent is particularly important 
since the donor does not receive any medical benefit from the procedure itself and 
undertakes the possibility of surgical risks including undergoing anesthesia, wound 
infection, and post operative bleeding; long term medical risks like earlier onset of 
hypertension or end-stage renal disease; and short- and long-term psychological and 
financial risks. Although some scientists believe there are possible benefits like increased 
self-esteem for those who donate their kidneys, the data are not definitive, since 
dissatisfied donors may not participate in follow-up research.2, 7, 14, 18, 19  Additionally some 
research indicates that a significant portion of donors experience short term depression, 
while a small percentage of donors, usually linked to a bad outcome for the recipient or 
chronic pain, regret donation in the long term.20  
Major consensus statements have been published to provide recommendations for 
the care of live kidney donor.21, 22  There is consensus amongst transplant professionals 
internationally that informed consent for a living kidney donor should include an accurate 
conveyance of short-and long-term medical, psychosocial and financial risks and that all 
steps are taken to minimize such risks.21, 22  However, to date, the informed consent 
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process has not been standardized. Preliminary research has shown that physicians and 
transplant staff at a subset of transplant centers vary in how risky they perceive living 
donation to be and how they convey these risks to potential donors.3, 23-26  Since the 
aforementioned consensus statements were published, no international research across 
transplant centers has been conducted to assess what is being regularly communicated to 
potential living donors and the degree to which global practice variations exist regarding 
the evaluation and informed consent of living kidney donors.  Significant variability may 
indicate a need for further consensus building, practice translation and policy 
development.   
Therefore, we surveyed US and non-US transplant professionals attending the 
World Transplant Congress about their informed consent practices with living donors and 
compared how risk communication varied between them. We compared US to non-US 
participants since currently approximately 50% of the world’s living kidney donations 
occur in the US and because healthcare policy and medical culture in the US is 
sufficiently different from most other countries to warrant this comparison.  
METHODS 
 
SURVEY DESIGN AND CONTENT  
In order to design a comprehensive survey that was easy to complete, a thorough 
review of the literature regarding living kidney donation was performed. The review 
included materials on the short and long-term medical and psychosocial risks of living 
kidney donation as well as materials on current informed consent practices by 
professionals working in kidney transplant. Additionally, consensus statements and 
guidelines regarding living kidney donor evaluation and consent were reviewed.  
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 Based on this research, a 19-question survey addressing both the methods of 
conveying risk to potential kidney donors and the actual risk parameters conveyed to 
potential donors was drafted. The survey was designed to consist primarily of closed 
ended questions so as to ensure that the results were quantifiable. The survey was then 
independently circulated to ten physicians at various transplant centers for feedback and 
was modified accordingly. The survey was designed to take approximately ten minutes 
for a participant to complete. This length was decided upon based on feedback in order to 
ensure maximum participation and thus generalizability of results.  
The survey measured health professional demographics, how the respondent 
conveyed medical, psychosocial and financial risks to a potential donor and what risks 
were conveyed during the informed consent process. The survey was divided into three 
parts, namely A. Background, B. Risk Information and C. Informed Consent Practices. 
Section B was further subdivided into 3 areas: (i) Medical Risks (ii) Financial Risks and 
(iii) Psychosocial Risks. All questions were close ended with a built-in skip pattern.  For 
example, regarding medical risks, the respondent was asked to check what increase in 
relative risk of hypertension was conveyed to the donor. They had a choice of checking 
various boxes with relative risk increases or checking the “not discussed” box. For the 
psychosocial evaluations, the participants were asked whether a psychosocial evaluation 
was mandated for the donor. If so, they were asked what length of time was allocated for 
such an evaluation. For this follow up question, they were given 4 choices, less than 15 
minutes, 15 to 30 minutes, 30 to 60 minutes or greater than 60 minutes. For such 
questions they were asked to only check one of the answer choices. For other questions, 
such as what methods were used to convey potential risks to donors, the survey 
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participants were asked to check all the responses that applied. The only open ended 
questions in the survey were the demographic questions: name, contact, center location, 
and how many donor interactions the respondent had in the past year. 
The survey was approved by the Institutional Review Board at Yale University 
Medical Center. 
 
RESPONDENTS 
In order to solicit a broad range and large sample of transplant professionals, we 
assessed a variety of different survey distribution techniques including online survey 
distribution, mail distribution, email distribution and in person distribution. Based on 
conversations with a number of experts, we concluded that results were most reliable and 
respondents were most likely to participate if surveys were given to them in person in a 
place conducive to immediately filling out the survey.  Therefore, we decided to solicit 
survey participants at the largest gathering of transplant professionals to date, namely at 
the World Transplant Conference in Boston in July 2006. This opportunity was unique in 
that it brought together a variety of professionals such as nephrologists, transplant 
surgeons, transplant nurses and center coordinators, from around the world. It was the 
first time a joint international transplant conference was held  - combining the annual 
American Transplant Congress and the various conferences held by the International 
Congresses of the Transplantation Society. It was co-sponsored by the American Society 
of Transplant Surgeons (ASTS), The American Society of Transplant (AST) and The 
Transplantation Society (TTS).  
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In order to recruit survey participants, we decided individuals would be most 
likely to complete surveys when registering onsite for the conference. Distributing the 
surveys in the conference registration area allowed us to have a one on one conversation 
with conference attendees in order to assess whether they were involved with living 
kidney transplantation, in particular if they were involved in donor evaluation or 
management. If they stated they worked with living kidney donors, they were invited to 
fill out the survey. With the help of the conference administrators we were able to 
provide participants with a table on which to fill the survey out and pencils for doing so. 
If the participant stated they wanted more time to fill out the survey, they were instructed 
to fill it out at their leisure and to return it in any of six drop boxes located throughout the 
conference venue or to mail or fax the survey to us after they had completed it.  
In addition to recruiting survey participants during onsite registration, we also 
provided surveys to individuals attending any conference lectures having to do with 
living kidney donation. In such instances individuals were instructed that they could 
return their surveys at the end of the lecture in a box placed outside the lecture room or in 
any of the drop boxes located throughout the venue. Alternatively, as with those 
individuals recruited at registration, they were told they could return the surveys via mail 
or fax.  These two recruitment methods were employed to enable a representative sample 
of conference attendees involved in living kidney donation to be surveyed. In both cases, 
the respondents were not given any form of compensation. 
Consent for study participation was presumed upon returning the survey. An 
information sheet provided with the survey explained the purpose of the study and 
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indicated that all responses would be confidential. Permission to distribute the survey at 
the WTC was obtained from the Conference Planning Committee prior to the conference.  
 
DATA COLLECTION 
The surveys were returned in containers located throughout the conference center. 
The survey also included instructions to mail or fax surveys back to us after the 
conference. Of the 223 complete surveys we recovered, 220 were returned at the 
conference, two were received by mail and one by fax. Two of the surveys returned could 
not be used in the analysis, because only demographic data were provided.  Five surveys 
did not include country of origin and so could not be used in the comparative analysis. 
Thus the analysis was done using 216 surveys. Each survey was assigned a unique 
number in order to make the data confidential and the responses were entered into an 
Excel spreadsheet. The data were checked independently by two people for any 
typographical or data entry errors. 
 
STATISTICAL ANALYSIS 
Standard descriptive statistics were computed for all variables.  To assess 
differences between US and non-US respondents, chi-square tests were used for 
dichotomous variables and the Wilcoxon Rank-Sum test was used for ordinal variables.  
In cases where there were a small number of observations for dichotomous outcomes, 
Fisher's exact test was used.  Variables are listed in Table 3 and Table 4 along with the 
results. Respondents from the same transplant center were treated independently such that 
some centers may be represented greater than others (Table 1). All analyses were based 
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on the respondent, not on the transplant center. All analyses were conducted using SAS  
9.1 (SAS Institute Inc., Cary, NC, USA).  
 
RESULTS 
RESPONDENTS DEMOGRAPHICS & TIME SPENT INTERACTING WITH DONORS 
The survey respondents (n=216) represented 40 countries and 177 transplant 
centers. 48% (n=104) of the respondents were from US centers, representing 79 centers 
from 29 states (Table 1). The number of respondents from the various states ranged from 
1 (8 states) to 13 (PA); the number of centers per state represented ranged from 1 (11 
states) to 11 (PA).  The 112 participants from the other countries represented 98 centers. 
The number of participants per country ranged from 1 (16 countries) to 15 (UK). The 
number centers per country represented ranged from 1 (15 countries) to 11 (UK). 
Table 1. Countries Represented by Survey Respondents 
COUNTRIES (40) 
# of respondents 
n (%) 
# centers 
n (%) 
USA 104 (47) 79 (45) 
Argentina 3 (1) 3 (2) 
Australia 7 (3) 4 (2) 
Belgium 2 (1) 2 (1) 
Brazil 10 (5) 9 (5) 
Canada 6 (3) 6 (3) 
China 1 (<1) 1 (1) 
Columbia 2 (1) 2 (1) 
Denmark 1 (<1) 1 (1) 
Egypt 3 (1) 3 (2) 
France 1 (<1) 1 (1)  
Germany 10 (5) 8 (5) 
Greece 1 (<1) 1 (1) 
Guatemala 2 (1) 2 (1) 
India 5 (2) 5 (3) 
Indonesia 1 (<1) 1 (1) 
Ireland 1 (<1) 1 (1) 
Israel 1 (<1) 1 (1) 
Japan 2 (1) 2 (1) 
Korea 2 (1)  2 (1) 
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Kuwait 2 (1)  2 (1) 
Malaysia 1 (<1) 1 (1) 
Mexico 4 (2) 3 (2) 
Netherlands 2 (1) 2 (1) 
Norway 1 (<1) 1 (1) 
New Zealand 4 (2) 3 (2) 
Peru 1 (<1) 1 (1) 
Philippines 1 (<1) 1 (1) 
Poland 4 (2) 2 (1) 
Russia 1 (<1) 1 (1) 
Saudi Arabia 2 (1) 2 (1) 
Singapore 1 (<1) 1 (1) 
Slovakia 1 (<1) 1 (1) 
South Africa 2 (1) 2 (1) 
Spain 2 (1) 2 (1) 
Sweden 2 (1) 2 (1) 
Thailand 3 (1) 3 (2) 
Tunisia 1 (<1) 1 (1) 
Turkey 1 (<1) 1 (1) 
UK 15 (7) 11 (6) 
 
 
The majority of the survey respondents were physicians (78%) and nurses (11%). 
38% of the respondents were nephrologists and 28% were transplant surgeons. 14% of 
the respondents were transplant coordinators.  Compared to non-US respondents, more 
US transplant coordinators (26% v. 6%, p<0.001) and non-MDs (29% v. 10%, p<0.001) 
completed the survey than their counterparts outside of the US (Table 2).  
Most respondents (74%) spent greater than 20% of their time with living kidney 
donors, with over a third of respondents (38%) spending greater than 70% of their time 
with living kidney donors. Additionally, about a quarter of respondents (24%) was either 
the chairperson or director of their transplant programs. US versus non-US respondents 
did not differ in the nature or quantity of interactions with donors in the past year (Table 
2). Together the respondents interacted with over 10,500 potential donors per year.   
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Table 2: Demographics of Respondents: US v non-US. 
  
Respondents 
(Total n per 
question) 
US         
n (%)  
Non-US  
 n (%) 
P 
value 
 
Degree  208     
MD (Physician)  70 (71) 99 (90) <0.001 
RN (Nurse)  21 (21) 3 (3)   
PA (Physician Assistant)  2 (2) 0 (0)   
PhD (Doctorate)  1 (1) 1 (1)   
Other  4 (4) 7 (6)   
Profession  191       
Nephrologist  38 (40) 46 (48) 0.001 
Surgeon  22 (23) 38 (40)   
Psychiatrist/Psychologist  2 (2) 0 (0)   
Transplant Coordinator  25 (26) 6 (6)   
Nurse  6 (6) 2 (2)   
Other  3 (3) 3 (3)   
Proportion of Professional’s 
Time Spent with Living Kidney 
Donors 
208 
      
>70%  42 (41) 37 (35) 0.56 
20-70%   36 (35) 38 (36)   
5 – 20%  15 (15) 23 (22)   
<5%  9 (9) 8 (8)   
# Donor Interactions in previous 
year, median (range) 
208 
30 (3-425) 25 (0-400) 0.62 
 
PROCESS OF DONOR EVALUATION AND CONVEYING RISKS 
According to respondents, across US and non-US transplant centers, most 
potential donors were sent written material about living donor risk by mail before 
evaluation (88%). Most respondents conveyed risk information to donors in person 
during the medical evaluation (98%). Additionally, many respondents provided risk 
information to potential donors in writing (49%), over the telephone (13%) and by using 
video/DVD (19%).  
Overall 55% of respondents used greater than one method to convey risks to 
donors.  Survey respondents used a variety of terminology to convey risks to donors. 34% 
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of respondents stated the primarily used qualitative terms when describing risks of 
donation. 31% used absolute rates of risk, 16% used relative risk rates and 12% stated 
that the type of terminology they used varied from one donor to the next.  
A majority of the time, nephrologists or surgeons were involved in discussions 
regarding the medical risks of donation (84%, 56%), and usually multiple individuals 
discussed the medical risks of donation with the potential donor (56%). No respondent 
stated that medical risks of donation were not discussed.   
Transplant Coordinators or Social Workers generally discussed the financial risks 
of donation with the donors (51%, 46%). 41% of respondents stated that financial risks 
were discussed by more than one professional; however, 11% of the respondents stated 
that financial risks were not discussed with donors.  
Social Workers, Nephrologists and Psychiatrists or Psychologists were almost 
equally responsible for discussing the psychosocial risks of donation (49%, 45%, 44%); 
with 57% of respondents stating that more than one individual was responsible for 
discussing the psychosocial risks of donation with the potential donor and 1% of 
respondents stated that psychosocial risks were not discussed.  
 79% of respondents stated that their centers mandate psychosocial evaluations of 
potential donors.  These generally lasted longer than 30 minutes (81%).35% of 
respondents stated that their evaluations lasted longer than 60 minutes. 43% of 
respondents said these evaluations were done by social workers; 51% were done by either 
psychiatrists or psychologists.  
Overall, 69% of respondents stated that donors were asked to sign an official 
donation consent form prior to donation presented to them by a non-resident surgeon or 
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nephrologist (88%). 42% of respondents stated that their centers provided donors with 
access to support groups and 81% said their centers provided donors with long term 
follow up care. 89% of respondents say they discussed donor risks with recipients.  
 Regarding the comparative analysis, US respondents were more likely to report 
sending donors written materials prior to donation (95% vs. 83%, p = 0.007), require 
psychosocial evaluations of the potential donors  (92% vs. 68%, p <0.0001), have 
surgeons be responsible for obtaining written consent (74% vs. 50%, p < 0.001), and 
offer donors a support group (54% v. 32%, p<0.002). In contrast, respondents from non-
US centers were more likely to report that donors receive long-term follow up (96% v. 
64%; p <0.0001), and were more likely to sign a consent form specifically for organ 
donation (77% v. 61%, p <0.01) and have nephrologists responsible for obtaining consent 
(40% v. 5%, p<0.01). Psychosocial evaluations occurring at US and non-US transplant 
centers varied considerably.  In the US, respondents reported that social workers most 
commonly conducted the psychosocial evaluation of potential donors (89% v. 41%, 
p<0.01), with most of these evaluations taking longer than 30 minutes (91% v. 69%, 
p<0.01). 
Table 3. Process of Donor Evaluation and Informed Consent: US v. non-US 
  
Overall  
N (%) 
US  
n (%)                
Non-US  
n (%) P value 
How medical risks are conveyed        
Qualitative 73 (36) 36 (37) 37 (35) 0.35 
Relative 35 (17) 19 (19) 16 (15)   
Absolute 69 (34) 28 (29) 41 (39)   
Varies 25 (12) 13 (13) 12 (11)   
What methods are used to convey risks to potential 
donors         
In Person 204 (98) 99 (100) 105 (95) 0.03 
By Telephone 86 (41) 57 (58) 29 (45) 0.06 
Written Material 28 (13) 23 (23) 5 (5) <0.0001 
Video/DVD 42 (20) 30 (30) 12 (11) 0.001 
Donor receives written material prior to donation      
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   Yes 184 (88) 92 (95) 92 (83) 0.007 
   No 24 (12) 5 (5) 19 (17)  
Mandatory psycho-social assessment of all potential 
donors      
  Yes 167 (80) 92 (92) 75 (68) <0.0001 
  No 43 (20) 8 (8) 35 (32)  
Who is responsible for the psychosocial evaluation         
Psychiatrist 76 (44) 36 (38) 40 (51) 0.08 
Psychologist 71 (41) 34 (36) 28 (36) 0.54 
Social Worker 117 (68) 85 (89) 32 (41) <0.0001 
How long is the evaluation       0.004 
<15 minutes 5 (8) 0 (0) 4 (5)   
15 – 30 minutes 28 (16) 9 (10) 19 (25)   
30 – 60 minutes 77 (45) 50 (54) 27 (35)   
> 60 minutes 60 (35) 34 (37) 26 (34)   
Center provides donors access to a support group      
   Yes 84 (42) 50 (54) 34 (32) 0.002 
   No 115 (58) 43 (46) 72 (68)  
Center provides long term follow up      
  Yes 171 (81) 65 (64) 106 (96) <0.0001 
  No 41 (19) 37 (36) 4 (4)  
Center has a specific consent form for live organ 
donation      
  Yes 145 (69) 59 (61) 86 (77) 0.012 
  No 64 (31) 38 (39) 26 (23)  
Who is the person responsible for obtaining consent         
Nephrologist 48 (24) 5 (5) 43 (40) <0.0001 
Surgeon 124 (62) 70 (74) 54 (50) 0.0007 
Nurse/Nurse Practitioner 26 (13) 18 (19) 8 (7) 0.015 
Social Worker 8 (4) 0 (0) 8 (7) 0.007 
Nephrologist Trainee 5 (3) 1(1) 4 (4) 0.22 
Surgical Trainee 7 (4) 4 (4) 3 (3) 0.59 
Donor nephrectomy risks are discussed with kidney 
recipients      
  Yes 185 (89) 84 (83) 101 (93) 0.085 
  No 24 (11) 17 (17) 7 (7)  
Center would adopt a centralized informed consent 
template      
 Yes 159 (81) 77 (79) 82 (84) 0.001 
 No 37 (19) 21 (21) 16 (16)  
 
 
 
CONTENT OF RISK COMMUNICATION  
More than 90% of respondents discussed multiple possible long-term medical 
risks with living donors including: hypertension, proteinuria, premature death, premature 
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cardiac disease, chronic kidney disease, and the possibility of needing dialysis or a 
transplant, should their kidney fail in the future. However, respondents varied 
considerably in whether or not they conveyed an increased risk for the donor as compared 
to a non-donor. For example, 15% of respondents told donors there was no increased risk 
of developing hypertension, 81% told them there was an increased risk and 4% did not 
discuss hypertension with donors.  There was similar variation with regards to 
proteinuria: 15% stated there was no increased risk, 78% stated there was an increased 
risk and 7% did not discuss the risk. The variation in medical risk conveyance was even 
more pronounced for the risk of premature death and cardiac disease and the greatest for 
the risk of future chronic kidney disease and the possible requirement of dialysis or 
kidney transplant. For premature death, 66% of respondents stated no increased risk, 23% 
stated an increased risk, and 11% did not discuss this risk; for premature cardiac disease, 
61% stated no increased risk, 28% stated an increased risk post donation, and 10% did 
not discuss this risk. For the increased risk of developing future chronic kidney disease 
40% of respondents stated there was no increased risk with donation, 56% stated there 
was an increased risk and 5% did not discuss this risk. Similarly, for the risk of requiring 
dialysis or kidney transplantation in the future, while 48% of respondents stated that there 
was no increased risk of requiring such measures, 46% stated that there was an increased 
risk and 6% did not discuss this risk with donors.  
Fewer respondents discussed specific financial risks with potential donors. Of the 
five specific financial costs that donors may face that we listed, on average 41% of 
respondents did not discuss the specific cost.  Approximately two thirds of respondents 
did discuss loss of salary, travel costs and family care costs, whereas increased costs of 
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health insurance and rehabilitation were discussed by a little more than half of the 
respondents. When the costs were discussed there was again great variability regarding 
whether donors were told there would be no significant cost, or whether there were costs 
associated with donation. For example, with regards to the costs of family care during the 
donation process, 27% of respondents told donors there was no increased cost, 33% told 
donors there was an increased cost and 39% of respondents did not discuss the cost at all.  
 Although 78% of respondents discussed the potential of future improved 
psychosocial well being with their prospective donors (17% not discussed, 5 % stated 
improved psychosocial well being was not likely), they were less likely to inform donors 
about potentially negative psychosocial outcomes. For example, over a quarter of US 
respondents did not discuss the potentially stressful nature of transplant (27%, not 
discussed), the possibility of post-operative depression (24%) or suicidal ideation (36%), 
or the possibility of adverse effects to the donor’s marital or family life (23%).  If 
psychosocial risks were discussed, some health professionals told living donors that they 
were not likely to have these issues arise in their situation while others told donors that 
these risks were somewhat likely. For example, while 30% of respondents told potential 
donors that adverse effects on their marital/family life would not be likely, 48% of 
respondents stated that such risks were likely.   
Exploring differences in what risks were communicated to potential donors at US 
and non-US transplant centers, US transplant professionals were more likely to 
communicate to potential donors that they might have to go on dialysis or receive a 
transplant if their remaining kidney failed (57% v. 36%; p =0.01), to discuss with donors 
that they may have to pay travel costs to the transplant centers (63% v. 35%; p=0.001) 
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and discuss possible lost income while they recovered (59% v. 40%; p=0.01). There were 
no significant differences in the conveyance of psychosocial risks between US and non-
US respondents. 
Table 4. Risks Communicated with Potential Donors: US v. non-US Respondents 
  
Respondents 
(total n per 
question) 
US  
n (%) 
Non-US 
n (%) 
Medical Risks*   
Not 
Increased Increased 
Not 
Discussed 
Not 
Increased Increased  
Not 
Discussed 
P 
Value 
Hypertension 198 20 (21) 70 (74) 4 (4) 10 (10) 91 (88) 3 (3) 0.057 
Proteinuria 197 17 (18) 69 (74) 7 (8) 13 (13) 85 (82) 6 (6) 0.44 
Premature Death 199 60 (64) 27(29) 7 (7) 72 (69) 19 (18) 14 (14) 0.12 
Premature Cardio 
Vascular Disease 197 60 (64) 25 (27) 9 (10) 61 (59) 31 (30) 11 (11) 0.80 
Chronic Kidney 
Disease 196 35 (38) 54 (59) 3 (3) 43 (41) 55 (53) 6 (6) 0.58 
Requirement of 
Dialysis/Kidney 
Transplant 197 37 (40) 52 (57) 3 (3) 58 (55) 38 (36) 9 (9) 0.01 
Financial Costs   No Cost Cost 
Not 
Discussed No Cost Cost 
Not 
Discussed 
P 
Value 
Travel Expenses 144 5 (8) 38 (63) 17 (28) 21 (25) 29 (35) 34 (40) 0.001 
Loss of Work 
Days 147 6 (10) 35 (59) 18 (31) 24 (27) 35 (40) 29 (33) 0.019 
Family Care 
Needs 142 16 (28) 18 (32) 23 (40) 23 (29) 29 (29) 33 (42) 0.95 
Increased Cost of 
Insurance 149 29 (43) 8 (12) 36 (45) 33 (43) 8 (11) 35 (46) 0.96 
Rehabilitation 
Costs 136 28 (44) 4 (6) 31 (49) 31 (42) 10 (14) 32 (44) 0.37 
Total estimated 
cost 111 6 (13) 17 (37) 23 (50) 11 (17) 25 (38) 29 (45) 0.80 
Psychosocial 
Risks   
Not 
Likely 
Somewhat 
Likely 
Not 
Discussed 
Not 
Likely 
Somewhat 
Likely 
Not 
Discussed 
P 
Value 
Improved Well 
Being 171 4 (5) 58 (74) 16 (21) 5 (5) 75 (81) 13 (14) 0.53 
Recollection of 
time as 
traumatic/stressful 164 12 (16) 38 (51) 25 (33) 24 (27) 45 (51) 20 (22) 0.14 
Post Op 
Depression 162 18 (24) 34 (46) 22 (30) 27 (31) 44 (50) 17 (19) 0.28 
Suicidal Ideation 158 32 (44) 7 (10) 33 (46) 53 (62) 9 (10) 24 (28) 0.06 
Marital/Familial 
Life Adverse Eff. 164 17 (23) 35 (47) 22 (30) 32 (36) 43 (48) 15 (17) 0.07 
* We did not define any of the medical risks in the survey. 
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CONSENSUS BUILDING, PRACTICE TRANSLATION  
Finally, most (82%) respondents reported that they believe their center would be 
willing to adopt a centralized informed consent template. More non-US transplant 
professionals,  said they would be willing to adopt such a template as compared to the US 
respondents (84% v. 79%; p =0.001).  
 
DISCUSSION 
 
This study, an international study on informed consent practices during donor 
evaluation, reveals that the risks communicated to donors and the informed consent 
process vary considerably across transplant professionals, centers and countries. For a 
potential donor to truly make an informed choice whether to donate their kidney they 
must understand the medical, financial and psychosocial risks they face as compared to 
the alternative of not donating their kidney. Patients also need sufficient time to have a 
conversation with a health professional, to have risk percentages explained in a way that 
makes sense to them, to have education tailored to their level of health literacy, to be 
provided with additional materials to take home with them to review and discuss with 
their family members, and to be provided with ample opportunity to ask any questions 
the may have about the process of donation and risks associated with it.  
 
VARIATION IN RISKS CONVEYED 
This study uncovered several important problems that need to be addressed to 
improve the living donor informed consent process.  First, information about the medical 
risks that a potential donor may face is presented to donors at some transplant centers 
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inaccurately. We found, for example, that while 56% of practitioners told potential 
donors they had an increased risk of developing ESRD, 40% said that there was no 
increased risk or did not discuss the risk at all. Most research available to date indicates 
that while GFR does decrease following uninephrectomy, the likelihood of ESRD 
requiring dialysis increases only slightly.3, 11, 12   Some research does indicate that the risk 
of ESRD does not increase after donation.10, 27, 28  Although the variation in what risks are 
conveyed to the reader is probably due to the debate still occurring about what the actual 
risks to a living donor are, the result is that potential donors are making donation 
decisions based on different risk information depending on the center in which they 
undergo transplant evaluation.  
Second, discussion of financial and psychosocial outcomes does not always occur 
and the conclusions drawn by transplant professionals summarizing the current research 
are inconsistent.  In this study, and in others, information about financial and 
psychosocial risks to the donor was left out about by at least 30% of respondents.25   Even 
when discussed, the information communicated to donors varied. For example, although 
some research indicates that most donors are satisfied with their donation decision, 
current research also consistently shows that worsened familial relations are a possible 
but unlikely risk associated with donating a kidney (2 - 13%).14, 19, 29, 30  However, we 
found that while a large percentage of practitioners communicated to donors that 
donation may negatively affect familial life, many either inform donors that such effects 
are not likely or do not discuss this potential risk at all. Similarly, while most respondents 
discussed the potential improved psychosocial status of donors, many did not discuss the 
risk of donor regret, depression or recollection of the surgery as a traumatic experience. 
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Evidence for some risk of these negative psychosocial consequences can be found in the 
scientific literature surrounding living kidney donation.20   
 
VARIATION IN DONOR EVALUATION AND INFORMED CONSENT PROCESSES 
Inadequate provision of informed consent for prospective organ donors is not 
ethically sound clinical practice as it can undermine individuals’ ability to make 
autonomous medical decisions. Public awareness of unethical practices can threaten 
public trust in the system of transplantation and donation, which in turn, may decrease the 
percentage of individuals who volunteer to be living donors.31   In examining differences 
in the informed consent process across transplant centers, potential donors may or may 
not receive written material about living donor risk by mail, undergo a psychosocial or 
medical evaluation of a sufficient duration to get their questions answered, and sign a 
donor informed consent document.  
Mandatory psychosocial evaluation varied significantly between US and non-US 
centers despite an international consensus that psychosocial evaluations are necessary.21, 
22, 24, 25, 32, 33  Given the lack of medical benefit to the donor, living kidney donation 
continues to spark controversy – within the family, ethicists worry about coercion and 
with anonymous donation, ethicists worry about the psychological stability of the donor; 
thus a thorough psychosocial evaluation of potential donors is essential in ensuring 
donors are in fact making autonomous decisions.17  Given the recent increase in non-
related donations, and evidence that such evaluations can effectively rule out 
psychopathology amongst anonymous donors, this step in the evaluation process should 
become standard in all countries.22, 26, 34-37  
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Regarding country variation in informed consent processes, it is not clear why US 
centers would be more likely to send donors written information prior to donor evaluation 
as compared to international transplant centers. However, evidence indicates that having 
written material available for donor education prior to donation makes donors more 
comfortable with donation.38   Thus, consistently providing written materials to potential 
donors may significantly improve the informed consent process. Receiving written 
material prior to actual evaluation may also lead to increased donation.   
Additionally it is not immediately evident why non-US centers would be more 
likely to use specific organ donation consent forms, whereas US centers use more general 
surgical consent forms. Perhaps this variation is a result of the US being a more litigious 
society and hence less willing to modify basic written forms that have already been 
deemed appropriate by the legal system. Alternatively, it could be because as our data 
indicates, in the US surgeons are more likely to be responsible for informed consent and 
perhaps surgeons are more likely to prefer uniform consent forms for all their surgeries.  
Finally, regarding donor follow up, the finding that US centers are less likely to 
offer long term follow up for donors may be due to different government policies. The 
availability of national health insurance schemes in other countries may facilitate such 
follow up for donors. It is not as clear why non-US centers would be less likely to offer 
support groups; however, cultural differences may explain this variation. For example, in 
most non-Western cultures, patients commonly rely on family members for assistance 
with self-care management rather than rely primarily on themselves for their care.39, 40   
On the other hand, American health care expects patients to be self reliant after medical 
procedures.41   Accordingly, patients in the US may experience additional stress until they 
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are fully recovered and thus, may be more amenable to finding comfort in support 
groups. While these variations in follow-up and long-term support exist and may be 
explained by political and/or cultural differences, there is some evidence that donors, 
everywhere, would benefit from access to both long term care and support groups.42  
Furthermore, long-term care and follow up will lead to an increase in kidney 
donation in two ways. First, potential donors may be more willing to donate if they are 
assured that the transplant center will provide them with long-term care. Second, because 
of the concerns recipients have for donors, potential recipients may become more willing 
to accept kidneys from living donors if they are assured that transplant centers will treat 
the health sequelae that result from donating the kidney.4, 19, 42-44  For the reasons above, all 
centers should consider providing both long term care and support groups available to 
donors.  
In the US, the Centers of Medicare and Medicaid Services (CMS) have 
implemented conditions of participation that require a broadening of the follow-up and 
informed consent practices. As of March 2007, all US transplant centers must follow 
donors for 2 years after donor nephrectomy. This initial step should provide for a 
clarification on the immediate outcomes following donor nephrectomy; however, longer-
term assessment of outcomes following donation can only be obtained through the 
creation of a mandatory donor registry, which would track all outcomes of living kidney 
donors over the long term.  
The informed consent process mandated by CMS and currently developed by the 
OPTN/UNOS (Organ Procurement and Transplantation Network/United Network for 
Organ Sharing), outlines specific elements that transplant centers must fulfill during the 
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informed consent process. This should limit the variability in informed consent processes 
that were evident in this survey for US transplant centers. However, follow up surveys of 
practices must be conducted to ensure this occurs.  
 
STUDY STRENGTHS AND LIMITATIONS 
 
There were several limitations to our study. First, the survey was only available in 
English to attendees of the World Transplant Congress, thus non-English speaking 
conference attendees could not participate. As a result of this, it is not evident how 
generalizable the results of the survey are. However, sampling of professionals at over 
177 transplant centers internationally helps to overcome limitations in generalizability 
raised by this concern. It would have been helpful to compare non-responders to 
responders using demographic data; however detailed demographic data of all the 
Conference attendees were not available. Second, it was not possible to determine a true 
response rate for the survey. Given the broad range of WTC attendees including 
professionals working in non-kidney transplantation, non-clinician scientists, individuals 
working primarily with kidney recipients or with deceased donor kidneys, it was 
impossible to estimate the number of attendees who worked primarily with living kidney 
donors. Third, although the survey was pilot-tested with experts in transplant and 
informed consent issues, it had not been previously validated. Fourth, survey responses 
represent self-reported practices, which may not accurately reflect actual informed 
consent practices due to social desirability biases and it was not possible to accurately test 
how knowledgeable each respondent was about the general practices of their center. 
However, knowing that most of the participants spent a significant amount of their time 
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working with living donors helps in ensuring some substantial working relationship with 
the overall kidney donation program. Fifth, the closed-ended questions of the survey limit 
the respondents from providing information about the subtleties of informed consent 
practices conducted at their respective centers. Additionally, while nephrologists and 
transplant surgeons were overrepresented in the sample population, transplant 
coordinators, social workers, and psychologists were underrepresented in the sample. 
This disproportionate representation is a concern because the living kidney donor 
informed consent process is an iterative team-based process involving all of these 
disciplines.  Sixth, we did not survey about the risk and duration of prolonged post-
operative pain and incapacity. Finally, an individual’s responses may not represent the 
true policy of the transplant center, and as with all surveys, the framing of the questions 
may lead to inherent biases. 
 
RECOMMENDATIONS: 
 In summary, the variation in donor informed consent found in this study may be 
occurring as a function of not having definitive information about what risks donors face 
or due to the increasing pressures of increasing organ availability conflicting with the 
ethical obligations of providing complete donor information. Most likely, the variations 
in practices are a result of a combination of these two.  Our study reinforces and further 
develops previous articles that have also indicated significant geographic variation in 
informed consent practices.45, 46  
 We recommend establishing international practice guidelines for informed consent 
of living kidney donors. According to our survey results, there is significant interest in a 
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uniform informed consent template, and the next step may be to assess what such a 
template would actually look like. The benefits of universal guidelines for informed 
consent for living donors are numerous, such as reducing healthcare costs and improving 
efficiency of clinical practice by avoiding unnecessarily lengthy informed consent 
discussions, and ensuring that prospective donors are provided with sufficient 
information necessary for adequate decision making, which would reduce the occurrence 
of poor decision-making and subsequent low patient satisfaction. Additionally, in legal 
cases involving informed consent, courts would have a uniform process to turn to for 
evidence of best practices as opposed to relying on the testimony of individual physician 
experts. Some disadvantages of having a uniform consent template may include imposing 
cultural values and beliefs and foreign concepts onto other cultural groups that do not 
share such values and beliefs or concepts. Or conversely, a universal template developed 
in the US may not address concerns salient in other cultures.47, 48  Moreover, informed 
consent practices are generally shaped by the local health care organizational context in 
which they occur, which may therefore hinder standardization.  
 
 Overall, however, the development of evidence-based guidelines will help to ensure 
that adequate informed consent for living donation is guaranteed for all potential living 
donors at transplant centers nationally and internationally. Future research should 
ascertain how much time is needed for adequate donor decision making, from whom 
donors are most likely to retain risk information, what methods of risk conveyance are 
most effective for donor comprehension, and whether variations exist along other 
parameters such as size of program or UNOS region. 
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